Craig A. Barbarosh
CIK 1472457 · last filed 2026-09-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NXGN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
TUSTIN, CA 92782
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SBRA | Director | 159,033 | $19.35 | $3.08M | $31.8K | 71 | 2026-09-02 |
| EVH | Director | 95,031 | $4.43 | $421.0K | $17.6K | 8 | 2026-06-08 |
| LFCR | Director | 88,073 | $6.44 | $567.2K | $0 | 5 | 2024-07-10 |
| NEXTGEN HEALTHCARE, INC. (NXGN) Delisted | Director | 152,509 | $23.94 | $3.65M | -$998.1K | 14 | 2023-08-23 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 20,863 | $8.76 | $182.8K | $0 | 7 | 2022-06-07 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 0 | — | — | $0 | 3 | 2019-07-18 |
| Sabra Health Care REIT, Inc. (SBRAP) Delisted | Director | 58,059 | — | — | $0 | 13 | 2018-04-03 |
| BV | Director | 20,640 | $10.86 | $224.2K | $0 | 1 | 2017-10-02 |
| Sabra Health Care REIT, Inc. (SBRA.P) Delisted | Director | 46,881 | — | — | $25.0K | 32 | 2016-10-03 |
| Timber Pharmaceuticals, Inc. (BPMX) Delisted | Director | — | — | — | $0 | 3 | 2016-07-25 |
Recent Filings · Page 7 of 18
173 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-10-19 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Mixed | +5,501 | $57.0K | EDGAR |
| 2020-09-02 | SBRA | Grant (A) | +505 | $0 | EDGAR |
| 2020-08-19 | NEXTGEN HEALTHCARE, INC. (NXGN) Delisted | Grant (A) | +14,706 | $0 | EDGAR |
| 2020-06-11 | SBRA | Grant (A) | +7,055 | $0 | EDGAR |
| 2020-06-02 | SBRA | Grant (A) | +390 | $0 | EDGAR |
| 2020-06-02 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-03 | SBRA | Grant (A) | +395 | $0 | EDGAR |
| 2020-01-02 | SBRA | Grant (A) | +1,171 | $0 | EDGAR |
| 2019-12-03 | SBRA | Grant (A) | +339 | $0 | EDGAR |
| 2019-10-17 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.